Decibel Therapeutics is a biotech company focused on developing treatments for hearing and balance disorders. Their product candidates include gene therapies for congenital and acquired hearing loss, as well as otoprotection therapeutics to prevent hearing loss in cancer patients undergoing chemotherapy. The company has a strategic collaboration with Regeneron Pharmaceuticals and is headquartered in Boston, Massachusetts.